Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.8M Hold
129,518
– – 0.01% 436
2026
Q2
$13.8M Buy
129,518
+46,653
+56% +$5.65M 0.01% 470
2026
Q1
$13.6M Buy
82,865
+23,313
+39% +$3.58M 0.01% 445
2025
Q4
$10.4M Buy
+59,552
New +$10.9M 0.01% 500
2023
Q4
– Sell
-74,557
Closed -$1.88M – 713
2023
Q3
$1.88M Sell
74,557
-18,000
-19% -$412K ﹤0.01% 593
2023
Q2
$1.95M Sell
92,557
-28,700
-24% -$545K ﹤0.01% 594
2023
Q1
$2.07M Hold
121,257
– – ﹤0.01% 587
2022
Q4
$2.42M Hold
121,257
– – 0.01% 575
2022
Q3
$2.61M Hold
121,257
– – 0.01% 569
2022
Q2
$2.39M Hold
121,257
– – 0.01% 583
2022
Q1
$2.85M Buy
121,257
+19,157
+19% +$445K 0.01% 594
2021
Q4
$2.79M Hold
102,100
– – ﹤0.01% 616
2021
Q3
$2.81M Hold
102,100
– – 0.01% 607
2021
Q2
$2.91M Hold
102,100
– – 0.01% 614
2021
Q1
$3.48M Buy
+102,100
New +$3.9M 0.01% 591

Other funds holding INSM

Swedbank's INSM Position: Q3 2026 in Review

Swedbank held its Insmed (INSM) position steady in Q3 2026 at 129,518 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #436.

Swedbank first reported a position in INSM in Q1 2021 and has held it in 15 quarters since. 214 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Swedbank held 129,518 shares of Insmed worth $14.8M as of Q3 2026.
  • Swedbank left its Insmed share count unchanged in Q3 2026.
  • Insmed made up 0.01% of Swedbank's portfolio in Q3 2026, its #436 holding.
  • Swedbank first reported a position in Insmed in Q1 2021 and has held it in 15 quarters since.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.